Skip to main contentSkip to navigation
Sirius Investors
Regulus Therapeutics Inc.

Regulus Therapeutics Inc.

RGLS
NASDAQHealthcare

Revenue Analysis - RGLS

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

RGLS Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Strategic Alliances and Collaborations

0.0% of total revenue

$6.0K

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Strategic Alliances and Collaborations
3/31/2020$6.0K
9/30/2019$18.0K
6/30/2019$18.0K
3/31/2019$6.8M
9/30/2018$18.0K
6/30/2018$18.0K

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Declining Segments
Strategic Alliances and Collaborations-66.7%

Earnings Reports

Want to see how RGLS's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports